Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Uniqure Ord Shs
(NQ:
QURE
)
5.050
+0.140 (+2.85%)
Streaming Delayed Price
Updated: 3:27 PM EDT, May 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Uniqure Ord Shs
< Previous
1
2
3
4
Next >
Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8%
July 11, 2022
Among its other key ratings, Amsterdam-based gene therapy company Uniqure stock also has a 92 Composite Rating.
Via
Investor's Business Daily
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
June 24, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...
Via
Benzinga
UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial
June 23, 2022
Via
Benzinga
Analyst Ratings for uniQure
May 24, 2022
Within the last quarter, uniQure (NASDAQ:QURE) has observed the following analyst ratings:
Via
Benzinga
Recap: uniQure Q1 Earnings
May 02, 2022
uniQure (NASDAQ:QURE) reported its Q1 earnings results on Monday, May 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Mizuho Comments On UniQure's Upcoming Low-Dose Huntington's Gene Therapy Trial Data
June 13, 2022
The much-awaited one-year data for the entire low-dose cohort for UniQure NV's (NASDAQ: QURE) AMT-130 gene therapy in Huntington's disease is expected at any time.
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
June 13, 2022
The Meaning Behind Value Stocks
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
April 11, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022
March 17, 2022
Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,...
Via
Benzinga
uniQure: Q4 Earnings Insights
February 25, 2022
uniQure (NASDAQ:QURE) reported its Q4 earnings results on Friday, February 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 04, 2022
Good morning, investor! We're almost done with the week but we still need to go over the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Revisiting the Biggest Winners and Losers Since the COVID Crash Low
February 16, 2022
A look at how the average stock that’s currently in the S&P 1500 has done since the Covid crash low by sector.
Via
Talk Markets
5 Value Stocks To Watch In The Healthcare Sector
February 14, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
January 24, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 27, 2021
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
58 Biggest Movers From Yesterday
December 17, 2021
Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Down 2.5%; Calliditas Therapeutics Shares Spike Higher
December 16, 2021
Toward the end of trading Thursday, the Dow traded up 0.05% to 35,946.32 while the NASDAQ fell 2.5% to 15,179.38. The S&P also fell, dropping 0.80% to 4,672.38. The U.S. has...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
December 17, 2021
Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ:
Via
Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
December 16, 2021
UniQure NV (NASDAQ: QURE) announced initial observations on the first four patients enrolled in the lower-dose cohort of Phase 1/2 trial of AMT-130 for Huntington...
Via
Benzinga
Mid-Day Market Update: Gold Rises 2%; IronNet Shares Plummet
December 16, 2021
Midway through trading Thursday, the Dow traded up 0.67% to 36,166.39 while the NASDAQ fell 0.63% to 15,467.79. The S&P also rose, gaining 0.20% to 4,719.09. The U.S. has the...
Via
Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
December 16, 2021
Gainers Calliditas Therapeutics AB (NASDAQ: CALT) shares climbed 28.7% to $24.13 after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; Accenture Beats Q1 Estimates
December 16, 2021
Following the market opening Thursday, the Dow traded up 0.49% to 36,102.31 while the NASDAQ fell 0.68% to 15,460.25. The S&P also rose, gaining 0.08% to 4,713.43. The U.S....
Via
Benzinga
CSL Behring, UniQure's Hemophilia B Gene Therapy Hits Primary Endpoint
December 09, 2021
CSL Behring and uniQure N.V.'s (NASDAQ: QURE) etranacogene dezaparvovec, a hemophilia B gene therapy, achieved the pre-specified primary endpoint of non-...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
November 22, 2021
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021
October 27, 2021
Upgrades According to Credit Suisse, the prior rating for Mercer International Inc (NASDAQ:
Via
Benzinga
Director Of Uniqure Sold $164.75 Thousand In Stock
September 22, 2021
Robert Gut, Director at Uniqure (NASDAQ:QURE), made a large insider sell on September 21, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
5 Value Stocks In The Healthcare Sector
September 20, 2021
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal
September 14, 2021
Gene therapy is set to become one of the most vital spaces with high prospects in the biotech sector.
Via
Talk Markets
72 Biggest Movers From Yesterday
September 08, 2021
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
September 07, 2021
Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.